Skip to main content

Characterization of Users of New Molecular Entities Approved in 2021 in TriNetX: An Updated Descriptive Analysis

    Basic Details
    Date Posted
    Medical Product
    new molecular entities (NMEs)

    This analysis aimed to characterize users of 51 new molecular entities (NMEs) that were approved by the FDA in 2021 in the TriNetX Live™ platform. This query ran on February 13, 2024.

    This report contains data from 59 health care organizations (HCOs), provided through the TriNetX Live™ platform in their USA Network with Minimal Shift from December 18, 2020 to December 31, 2023.

    Additional Details
    FDA Center
    Time Period
    December 18, 2020 - December 31, 2023
    Analysis Type
    TriNetX Analysis
    Population / Cohort
    All Individuals
    Data Sources
    TriNetX USA Network